BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 10, 2010
View Archived Issues
Novartis gains exclusive rights to Debiopharm's alisporivir for hepatitis C
Read More
ALK-Abello reports final follow-up results from GT-08 trial of Grazax
Read More
VaxGen stockholder vote insufficient to approve merger with OXiGENE
Read More
Westaim merges with Nucryst to form Westaim Holdings
Read More
SciClone and Sigma-Tau report topline results of Zadaxin trial in H1N1
Read More
Ono Pharmaceutical reports results from third quarter of 2009, ended December 31
Read More
Phase I data support safety and tolerability of ADMVA HIV candidate vaccine
Read More
Denosumab superior to Zometa in prostate cancer patients with bone metastases
Read More
Hsp32 implicated in protective effects of celastrol in hair cell death
Read More
Palatin Technologies doses first male cohort in bremelanotide safety trial
Read More
Baclofen shown to inhibit salicylate and noise-induced tinnitus in rats
Read More
Minocycline ameliorates neomycin-induced hearing loss in gerbils
Read More
Novel PET imaging agents identified by Merck & Co.
Read More
Takeda studies concomitant use of dexlansoprazole and other PPIs with Plavix
Read More
Sirtris Pharmaceuticals discovers SIRT activators
Read More
Novel ACC inhibitors in early development at Pfizer
Read More
Progenics reports the identification of a wide range of PI3K inhibitors
Read More
GSK claims novel triple monoamine reuptake inhibitors for affective disorders
Read More
Kamada enrolls first patient in pivotal study of inhaled AAT
Read More
Xoma initiates phase IIb dose-finding XOMA-052 trial in type 2 diabetes
Read More
Psyadon initiates clinical trial of ecopipam in Lesch-Nyhan disease
Read More
Chelsea Therapeutics advances neurogenic orthostatic hypotension program
Read More
Tibotec's Prezista approved in Canada as part of combination therapy for pediatric HIV
Read More
AnaptysBio and Merck & Co. enter into antibody development collaboration
Read More